Celgene Corporation EBITDA Margin 2010-2019 | CELG

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Celgene Corporation (CELG) over the last 10 years. The current EBITDA margin for Celgene Corporation as of September 30, 2019 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2019-09-30 $16.98B $8.52B 50.16%
2019-06-30 $16.35B $7.96B 48.69%
2019-03-31 $15.77B $7.35B 46.61%
2018-12-31 $15.28B $5.83B 38.13%
2018-09-30 $14.73B $5.19B 35.26%
2018-06-30 $14.12B $4.51B 31.96%
2018-03-31 $13.58B $4.29B 31.61%
2017-12-31 $13.00B $5.18B 39.82%
2017-09-30 $12.50B $4.93B 39.45%
2017-06-30 $12.20B $4.26B 34.93%
2017-03-31 $11.68B $3.76B 32.16%
2016-12-31 $11.23B $3.67B 32.69%
2016-09-30 $10.81B $3.63B 33.54%
2016-06-30 $10.16B $3.27B 32.16%
2016-03-31 $9.69B $2.85B 29.39%
2015-12-31 $9.26B $2.66B 28.71%
2015-09-30 $8.78B $2.48B 28.19%
2015-06-30 $8.43B $3.04B 36.12%
2015-03-31 $8.02B $3.38B 42.18%
2014-12-31 $7.67B $2.89B 37.66%
2014-09-30 $7.34B $2.47B 33.67%
2014-06-30 $7.03B $2.28B 32.43%
2014-03-31 $6.76B $2.09B 30.88%
2013-12-31 $6.49B $2.18B 33.62%
2013-09-30 $6.19B $2.17B 35.12%
2013-06-30 $5.93B $2.19B 36.96%
2013-03-31 $5.70B $2.04B 35.84%
2012-12-31 $5.51B $2.03B 36.87%
2012-09-30 $5.34B $2.12B 39.62%
2012-06-30 $5.17B $2.07B 40.07%
2012-03-31 $4.99B $1.97B 39.56%
2011-12-31 $4.84B $1.81B 37.30%
2011-09-30 $4.63B $1.63B 35.25%
2011-06-30 $4.29B $1.48B 34.45%
2011-03-31 $3.96B $1.30B 32.83%
2010-12-31 $3.63B $1.25B 34.45%
2010-09-30 $3.32B $1.24B 37.25%
2010-06-30 $3.10B $1.13B 36.52%
2010-03-31 $2.88B $1.10B 38.11%
2009-12-31 $2.69B $0.97B 35.99%